EP-80061

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameEP-80061

Drug Alias NameHeparan Sulfate Mimetics (Endotis)EP-8000 Program (Endotis)heparanase inhibitors (Endotis)EP-80061

ClassificationSmall molecules > Carbohydrate > Oligosaccharide

Mechanisms of ActionHeparanase inhibitors

TargetsHeparanase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEndotis Pharma SA

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEndotis Pharma SA

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A